Korean J Nucl Med.
2000 Jun;34(3):159-168.
Radioligands for Imaging Dopamine and Serotonin Receptors and Transporters
Abstract
-
In the 1980s, techniques to image the human subjects in a rhree-dimensiona1 direction
were developed, Two major techniques are SPECT (Single Photon Emission Computed Tomography)
and PET (Positron Emission Tomography) which allow the detector to detect a single photon
or annihilation photons emitted from the subjects injected with radiopharmaceuticals. Since
the latter two techniques can measure the density of receptors, enzymes and transporters in
living human, it may be very important project to develop selective methods of labeling with
radionuclides and to develop new radiopharmaceuticals. There has been a considerable
interest in developing new compounds which specifically bind to dopamine and serotonin
receptor and transporters, and it will be thus very useful to label those compounds with
radionuclides in order to gain a better understanding in biochemical and pharmacological
interactions in living human. This review rnentions the characteristics of radioligands
for the imaging of dopamine and serotonin receptors and transporters. Although significant
progress has been achieved in the development of new PET and SPECT ligands for in vivo
imaging of those receptors and transporters, there are continuous needs of new diagnostic
radioligands,